Prelude Capital Management’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-525,759
| Closed | -$3.07M | – | 1469 |
|
|
2025
Q1 | $3.07M | Buy |
+525,759
| New | +$2.77M | 0.23% | 82 |
|
|
2024
Q3 | – | Sell |
-24,044
| Closed | -$202K | – | 1587 |
|
|
2024
Q2 | $202K | Buy |
+24,044
| New | +$256K | 0.01% | 1002 |
|
|
2023
Q3 | – | Sell |
-12,625
| Closed | -$321K | – | 1397 |
|
|
2023
Q2 | $321K | Buy |
+12,625
| New | +$364K | 0.02% | 612 |
|
|
2022
Q4 | – | Sell |
-4,332
| Closed | -$202K | – | 1668 |
|
|
2022
Q3 | $202K | Buy |
+4,332
| New | +$201K | 0.01% | 1072 |
|
|
2021
Q3 | – | Sell |
-5,380
| Closed | -$892K | – | 2086 |
|
|
2021
Q2 | $892K | Buy |
+5,380
| New | +$840K | 0.03% | 674 |
|
|
2019
Q4 | – | Sell |
-1,010
| Closed | -$87K | – | 2322 |
|
|
2019
Q3 | $87K | Sell |
1,010
-270
| -21% | -$20.4K | ﹤0.01% | 999 |
|
|
2019
Q2 | $83K | Buy |
1,280
+587
| +85% | +$36.5K | ﹤0.01% | 1005 |
|
|
2019
Q1 | $43K | Buy |
+693
| New | +$32.6K | ﹤0.01% | 1160 |
|
|
2018
Q4 | – | Sell |
-18,912
| Closed | -$1.08M | – | 2232 |
|
|
2018
Q3 | $1.08M | Buy |
18,912
+12,253
| +184% | +$766K | 0.06% | 354 |
|
|
2018
Q2 | $532K | Sell |
6,659
-4,241
| -39% | -$352K | 0.03% | 518 |
|
|
2018
Q1 | $945K | Sell |
10,900
-5,958
| -35% | -$481K | 0.07% | 294 |
|
|
2017
Q4 | $1.16M | Buy |
16,858
+2,191
| +15% | +$175K | 0.09% | 225 |
|
|
2017
Q3 | $1.33M | Sell |
14,667
-18,776
| -56% | -$1.61M | 0.12% | 188 |
|
|
2017
Q2 | $2.49M | Buy |
33,443
+20,380
| +156% | +$1.63M | 0.24% | 89 |
|
|
2017
Q1 | $1.22M | Buy |
13,063
+5,414
| +71% | +$490K | 0.12% | 206 |
|
|
2016
Q4 | $556K | Sell |
7,649
-2,573
| -25% | -$220K | 0.07% | 302 |
|
|
2016
Q3 | $1.07M | Buy |
10,222
+5,194
| +103% | +$469K | 0.11% | 202 |
|
|
2016
Q2 | $371K | Buy |
5,028
+2,343
| +87% | +$159K | 0.05% | 342 |
|
|
2016
Q1 | $151K | Buy |
2,685
+2,020
| +304% | +$119K | 0.02% | 638 |
|
|
2015
Q4 | $45K | Sell |
665
-1,900
| -74% | -$102K | 0.01% | 1069 |
|
|
2015
Q3 | $119K | Buy |
+2,565
| New | +$124K | 0.02% | 787 |
|
Other funds holding NVRO
Prelude Capital Management's NVRO Position: Q2 2025 in Review
Prelude Capital Management sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 525,759 shares — an estimated $3.07M sold.
Prelude Capital Management first reported a position in NVRO in Q3 2015 and held it in 21 quarters. The position peaked at $3.07M in Q1 2025. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- Prelude Capital Management reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- Prelude Capital Management sold 525,759 NEVRO CORP. shares in Q2 2025, an estimated $3.07M.
- Prelude Capital Management first reported a position in NEVRO CORP. in Q3 2015 and held it in 21 quarters.
- Prelude Capital Management's NEVRO CORP. position peaked at $3.07M in Q1 2025.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.